Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish population

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Standard

Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish population. / Merlo, Juan; Broms, Kristian; Lindblad, Ulf; Björck-Linne, Agneta; Liedholm, Hans; Östergren, Per-Olof; Erhardt, Leif RW; Råstam, Lennart; Melander, Arne.

I: European Journal of Clinical Pharmacology, Vol. 57, Nr. 1, 2001, s. 71-75.

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Harvard

APA

CBE

MLA

Vancouver

Author

RIS

TY - JOUR

T1 - Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish population

AU - Merlo, Juan

AU - Broms, Kristian

AU - Lindblad, Ulf

AU - Björck-Linne, Agneta

AU - Liedholm, Hans

AU - Östergren, Per-Olof

AU - Erhardt, Leif RW

AU - Råstam, Lennart

AU - Melander, Arne

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Community Medicine (013241810), Division of Social Medicine and Global Health (013241820), Emergency medicine/Medicine/Surgery (013240200), Social Epidemiology (013241850), Internal Medicine Research Unit (013242520), Psychiatry/Primary Care/Public Health (013240500)

PY - 2001

Y1 - 2001

N2 - Objective: Individual-based studies on restricted geographical settings have suggested that nonsteroidal anti-inflammatory drugs (NSAIDs) may precipitate congestive heart failure. As NSAID use is very extensive, it might increase the occurrence of symptomatic heart failure in the general population. Therefore, in order to study the impact of NSAID utilisation (prescribed and over the counter) on hospitalised heart failure in an entire country (Sweden), we performed an ecological analysis, a design appropriate for studying large geographical areas. Methods: We employed weighted (population size) ecological linear regression to study the association between outpatient utilisation of NSAIDs during 1989-1993 and hospitalised heart failure in 1993 in 283 of Sweden's 288 municipalities. Data were adjusted for age and ender proportions, socio-economic factors, latitude and utilisation of cardiovascular drugs, aspirin, low-dose aspirin and paracetamol. Results: The unadjusted relative risk of hospitalised heart failure for each increase of one standard deviation of NSAID utilisation (5.8 defined daily doses/1000 inhabitants/day) was 1.23 [95% confidence interval (CI) 1.18, 1.27]. After adjustments, the relative risk was 1.08 (95% CI 1.04, 1.12); the corresponding values if aspirin (non-low-dose) was included as an NSAID were 1.26 (95% CI 1.23, 1.28) and 1.07 (95% CI 1.04, 1.10). There was no such adjusted association with the utilisation of paracetamol - 0.95 (95% CI 0.92, 0.98). Conclusion: The NSAID-heart failure association already established by individual-based studies on restricted geographical settings was corroborated in the present ecological study based on the whole population of an entire country (Sweden). Efforts should be made to promote a rational use of NSAIDs in the general population.

AB - Objective: Individual-based studies on restricted geographical settings have suggested that nonsteroidal anti-inflammatory drugs (NSAIDs) may precipitate congestive heart failure. As NSAID use is very extensive, it might increase the occurrence of symptomatic heart failure in the general population. Therefore, in order to study the impact of NSAID utilisation (prescribed and over the counter) on hospitalised heart failure in an entire country (Sweden), we performed an ecological analysis, a design appropriate for studying large geographical areas. Methods: We employed weighted (population size) ecological linear regression to study the association between outpatient utilisation of NSAIDs during 1989-1993 and hospitalised heart failure in 1993 in 283 of Sweden's 288 municipalities. Data were adjusted for age and ender proportions, socio-economic factors, latitude and utilisation of cardiovascular drugs, aspirin, low-dose aspirin and paracetamol. Results: The unadjusted relative risk of hospitalised heart failure for each increase of one standard deviation of NSAID utilisation (5.8 defined daily doses/1000 inhabitants/day) was 1.23 [95% confidence interval (CI) 1.18, 1.27]. After adjustments, the relative risk was 1.08 (95% CI 1.04, 1.12); the corresponding values if aspirin (non-low-dose) was included as an NSAID were 1.26 (95% CI 1.23, 1.28) and 1.07 (95% CI 1.04, 1.10). There was no such adjusted association with the utilisation of paracetamol - 0.95 (95% CI 0.92, 0.98). Conclusion: The NSAID-heart failure association already established by individual-based studies on restricted geographical settings was corroborated in the present ecological study based on the whole population of an entire country (Sweden). Efforts should be made to promote a rational use of NSAIDs in the general population.

KW - NSAID

KW - Heart failure

KW - Ecological studies

U2 - 10.1007/s002280100266

DO - 10.1007/s002280100266

M3 - Article

VL - 57

SP - 71

EP - 75

JO - European Journal of Clinical Pharmacology

JF - European Journal of Clinical Pharmacology

SN - 1432-1041

IS - 1

ER -